UniProt ID | ARNT_HUMAN | |
---|---|---|
UniProt AC | P27540 | |
Protein Name | Aryl hydrocarbon receptor nuclear translocator | |
Gene Name | ARNT | |
Organism | Homo sapiens (Human). | |
Sequence Length | 789 | |
Subcellular Localization | Nucleus. | |
Protein Description | Required for activity of the Ah (dioxin) receptor. This protein is required for the ligand-binding subunit to translocate from the cytosol to the nucleus after ligand binding. The complex then initiates transcription of genes involved in the activation of PAH procarcinogens. The heterodimer binds to core DNA sequence 5'-TACGTG-3' within the hypoxia response element (HRE) of target gene promoters and functions as a transcriptional regulator of the adaptive response to hypoxia (By similarity). The heterodimer ARNT:AHR binds to core DNA sequence 5'-TGCGTG-3' within the dioxin response element (DRE) of target gene promoters and activates their transcription. [PubMed: 28396409] | |
Protein Sequence | MAATTANPEMTSDVPSLGPAIASGNSGPGIQGGGAIVQRAIKRRPGLDFDDDGEGNSKFLRCDDDQMSNDKERFARSDDEQSSADKERLARENHSEIERRRRNKMTAYITELSDMVPTCSALARKPDKLTILRMAVSHMKSLRGTGNTSTDGSYKPSFLTDQELKHLILEAADGFLFIVSCETGRVVYVSDSVTPVLNQPQSEWFGSTLYDQVHPDDVDKLREQLSTSENALTGRILDLKTGTVKKEGQQSSMRMCMGSRRSFICRMRCGSSSVDPVSVNRLSFVRNRCRNGLGSVKDGEPHFVVVHCTGYIKAWPPAGVSLPDDDPEAGQGSKFCLVAIGRLQVTSSPNCTDMSNVCQPTEFISRHNIEGIFTFVDHRCVATVGYQPQELLGKNIVEFCHPEDQQLLRDSFQQVVKLKGQVLSVMFRFRSKNQEWLWMRTSSFTFQNPYSDEIEYIICTNTNVKNSSQEPRPTLSNTIQRPQLGPTANLPLEMGSGQLAPRQQQQQTELDMVPGRDGLASYNHSQVVQPVTTTGPEHSKPLEKSDGLFAQDRDPRFSEIYHNINADQSKGISSSTVPATQQLFSQGNTFPPTPRPAENFRNSGLAPPVTIVQPSASAGQMLAQISRHSNPTQGATPTWTPTTRSGFSAQQVATQATAKTRTSQFGVGSFQTPSSFSSMSLPGAPTASPGAAAYPSLTNRGSNFAPETGQTAGQFQTRTAEGVGVWPQWQGQQPHHRSSSSEQHVQQPPAQQPGQPEVFQEMLSMLGDQSNSYNNEEFPDLTMFPPFSE | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MAATTANPE ------CCCCCCCHH | 17.32 | 22814378 | |
11 | Phosphorylation | TTANPEMTSDVPSLG CCCCHHHCCCCCCCC | 21.80 | - | |
58 | Acetylation | DDGEGNSKFLRCDDD CCCCCCCCEEECCCH | 53.03 | 25953088 | |
58 | Ubiquitination | DDGEGNSKFLRCDDD CCCCCCCCEEECCCH | 53.03 | - | |
58 | Sumoylation | DDGEGNSKFLRCDDD CCCCCCCCEEECCCH | 53.03 | 28112733 | |
68 | Phosphorylation | RCDDDQMSNDKERFA ECCCHHCCCCHHHHH | 35.92 | 19664994 | |
77 | Phosphorylation | DKERFARSDDEQSSA CHHHHHCCHHHCCHH | 46.08 | 29255136 | |
82 | Phosphorylation | ARSDDEQSSADKERL HCCHHHCCHHHHHHH | 25.99 | 21712546 | |
83 | Phosphorylation | RSDDEQSSADKERLA CCHHHCCHHHHHHHH | 39.93 | 21712546 | |
95 | Phosphorylation | RLARENHSEIERRRR HHHHHCHHHHHHHHH | 52.42 | 29083192 | |
120 | Phosphorylation | SDMVPTCSALARKPD HHHHCHHHHHCCCCC | 28.88 | - | |
125 | Acetylation | TCSALARKPDKLTIL HHHHHCCCCCHHHHH | 52.54 | 25953088 | |
128 | Acetylation | ALARKPDKLTILRMA HHCCCCCHHHHHHHH | 56.93 | 25953088 | |
143 | Methylation | VSHMKSLRGTGNTST HHHHHHHCCCCCCCC | 47.95 | - | |
149 | Phosphorylation | LRGTGNTSTDGSYKP HCCCCCCCCCCCCCC | 28.62 | 28555341 | |
155 | Ubiquitination | TSTDGSYKPSFLTDQ CCCCCCCCCCCCCHH | 35.56 | - | |
240 | Ubiquitination | TGRILDLKTGTVKKE HHCEEECCCCCCCCC | 44.57 | - | |
245 | Sumoylation | DLKTGTVKKEGQQSS ECCCCCCCCCCCHHH | 44.97 | - | |
245 | Sumoylation | DLKTGTVKKEGQQSS ECCCCCCCCCCCHHH | 44.97 | 12354770 | |
251 | Phosphorylation | VKKEGQQSSMRMCMG CCCCCCHHHHCHHHC | 20.43 | 23403867 | |
252 | Phosphorylation | KKEGQQSSMRMCMGS CCCCCHHHHCHHHCC | 13.18 | 22210691 | |
259 | Phosphorylation | SMRMCMGSRRSFICR HHCHHHCCCCCEEEE | 9.53 | 23403867 | |
262 | Phosphorylation | MCMGSRRSFICRMRC HHHCCCCCEEEECCC | 20.18 | 24719451 | |
278 | Phosphorylation | SSSVDPVSVNRLSFV CCCCCCCCHHHHHHH | 21.04 | 29449344 | |
283 | Phosphorylation | PVSVNRLSFVRNRCR CCCHHHHHHHHHHHH | 20.61 | 24719451 | |
346 | Phosphorylation | AIGRLQVTSSPNCTD EEECEEEECCCCCCC | 15.55 | 29978859 | |
347 | Phosphorylation | IGRLQVTSSPNCTDM EECEEEECCCCCCCC | 44.96 | 28348404 | |
348 | Phosphorylation | GRLQVTSSPNCTDMS ECEEEECCCCCCCCC | 15.69 | 29978859 | |
352 | Phosphorylation | VTSSPNCTDMSNVCQ EECCCCCCCCCCCCC | 41.18 | 29978859 | |
355 | Phosphorylation | SPNCTDMSNVCQPTE CCCCCCCCCCCCCHH | 28.99 | 29978859 | |
417 | Ubiquitination | DSFQQVVKLKGQVLS HHHHHHHHHHCCEEE | 45.70 | - | |
417 | Ubiquitination | DSFQQVVKLKGQVLS HHHHHHHHHHCCEEE | 45.70 | - | |
419 | Ubiquitination | FQQVVKLKGQVLSVM HHHHHHHHCCEEEEE | 41.39 | - | |
419 | Ubiquitination | FQQVVKLKGQVLSVM HHHHHHHHCCEEEEE | 41.39 | - | |
487 | Phosphorylation | QRPQLGPTANLPLEM CCCCCCCCCCCCCCC | 26.78 | 29978859 | |
496 | Phosphorylation | NLPLEMGSGQLAPRQ CCCCCCCCCCCCCHH | 23.27 | 29978859 | |
508 | Phosphorylation | PRQQQQQTELDMVPG CHHHHCCCHHCCCCC | 33.89 | 29978859 | |
539 | Phosphorylation | TTTGPEHSKPLEKSD ECCCCCCCCCCCCCC | 34.02 | 24719451 | |
540 | Acetylation | TTGPEHSKPLEKSDG CCCCCCCCCCCCCCC | 56.37 | 26051181 | |
544 | Ubiquitination | EHSKPLEKSDGLFAQ CCCCCCCCCCCCCCC | 62.62 | - | |
558 | Phosphorylation | QDRDPRFSEIYHNIN CCCCCCHHHHHHCCC | 25.10 | 21945579 | |
561 | Phosphorylation | DPRFSEIYHNINADQ CCCHHHHHHCCCCCC | 5.69 | 21945579 | |
593 | Phosphorylation | QGNTFPPTPRPAENF CCCCCCCCCCCHHHC | 31.97 | - | |
626 | O-linked_Glycosylation | GQMLAQISRHSNPTQ HHHHHHHHHCCCCCC | 16.32 | 30059200 | |
629 | O-linked_Glycosylation | LAQISRHSNPTQGAT HHHHHHCCCCCCCCC | 43.31 | 30059200 | |
636 | Phosphorylation | SNPTQGATPTWTPTT CCCCCCCCCCCCCCC | 28.24 | - | |
638 | Phosphorylation | PTQGATPTWTPTTRS CCCCCCCCCCCCCCC | 37.30 | - | |
640 | Phosphorylation | QGATPTWTPTTRSGF CCCCCCCCCCCCCCC | 17.15 | - | |
642 | O-linked_Glycosylation | ATPTWTPTTRSGFSA CCCCCCCCCCCCCCH | 27.71 | 30059200 | |
643 | O-linked_Glycosylation | TPTWTPTTRSGFSAQ CCCCCCCCCCCCCHH | 24.84 | 30059200 | |
645 | O-linked_Glycosylation | TWTPTTRSGFSAQQV CCCCCCCCCCCHHHH | 41.94 | 30059200 | |
648 | Phosphorylation | PTTRSGFSAQQVATQ CCCCCCCCHHHHHHH | 28.79 | 28555341 | |
654 | Phosphorylation | FSAQQVATQATAKTR CCHHHHHHHHCCCCC | 21.63 | 23401153 | |
657 | Phosphorylation | QQVATQATAKTRTSQ HHHHHHHCCCCCCCC | 20.90 | 28555341 | |
669 | Phosphorylation | TSQFGVGSFQTPSSF CCCCCCCCCCCCCCC | 16.27 | - | |
686 | Phosphorylation | MSLPGAPTASPGAAA CCCCCCCCCCCCCCC | 38.95 | 28348404 | |
688 | Phosphorylation | LPGAPTASPGAAAYP CCCCCCCCCCCCCCC | 26.75 | 28348404 | |
788 | Phosphorylation | LTMFPPFSE------ CCCCCCCCC------ | 48.44 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
77 | S | Phosphorylation | Kinase | CSNK2A1 | P68400 | GPS |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of ARNT_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ARNT_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-77, AND MASSSPECTROMETRY. |